Clinical Trial Update: Botulinumtoxin A as a Treatment for Myalgia and Myofacial Pain in Patient With Temporomandibulardisorders [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating botulinum toxin A for myalgia and myofascial pain in temporomandibular disorders, currently recruiting in Region Stockholm.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Temporomandibular Disorders

Drugs mentioned

• Botulinumtoxin A (botulinum toxin type A)

Snippet

Sponsor: Region Stockholm | Conditions: Temporomandibular Disorder | Phase 3 | Status: RECRUITING